Senior insider sale
Executive Vice President at AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.56M
146.40K shares
What this filing means
SHAH NIKITA plans to sell 146.40K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $2.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001628280-26-056220
Officer· Executive Vice President
Since Mar 2026
146.40K
Shares to sell
$2.56M
Approx. market value
146.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
EQUITY COMPENSATION
EQUITY COMPENSATION
3/4/2025
17.53KEQUITY COMPENSATION
EQUITY COMPENSATION
3/3/2025
110.90KEQUITY COMPENSATION
EQUITY COMPENSATION
3/1/2025
17.97KTotal acquired146.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2025 | EQUITY COMPENSATION EQUITY COMPENSATION | 17.53K | — |
3/3/2025 | EQUITY COMPENSATION EQUITY COMPENSATION | 110.90K | — |
3/1/2025 | EQUITY COMPENSATION EQUITY COMPENSATION | 17.97K | — |
| Total | 146.40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
146.40K
Market value
$2.56M
8/12/2026
Total
Units
146.40K
Value
$2.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2026 | 146.40K | $2.56M | NASDAQ | Planned |
| Total | 146.40K | $2.56M | ||